CN111141850A - 对乙酰氨基酚原料药有关物质的液相检测分离方法 - Google Patents
对乙酰氨基酚原料药有关物质的液相检测分离方法 Download PDFInfo
- Publication number
- CN111141850A CN111141850A CN202010011431.3A CN202010011431A CN111141850A CN 111141850 A CN111141850 A CN 111141850A CN 202010011431 A CN202010011431 A CN 202010011431A CN 111141850 A CN111141850 A CN 111141850A
- Authority
- CN
- China
- Prior art keywords
- acetaminophen
- bulk drug
- acetic acid
- glacial acetic
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 title claims abstract description 80
- 229960005489 paracetamol Drugs 0.000 title claims abstract description 40
- 238000001514 detection method Methods 0.000 title claims abstract description 23
- 238000000926 separation method Methods 0.000 title claims abstract description 18
- 239000007791 liquid phase Substances 0.000 title claims abstract description 15
- 229940088679 drug related substance Drugs 0.000 title claims abstract description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 54
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000012071 phase Substances 0.000 claims abstract description 23
- 229960000583 acetic acid Drugs 0.000 claims abstract description 20
- 239000012362 glacial acetic acid Substances 0.000 claims abstract description 20
- 239000012535 impurity Substances 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000007788 liquid Substances 0.000 claims abstract description 16
- 238000010828 elution Methods 0.000 claims abstract description 14
- 239000012085 test solution Substances 0.000 claims abstract description 13
- 239000003814 drug Substances 0.000 claims abstract description 11
- 229940079593 drug Drugs 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000000945 filler Substances 0.000 claims abstract description 4
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 10
- 239000012488 sample solution Substances 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 4
- 239000012512 bulk drug substance Substances 0.000 claims 2
- 239000002994 raw material Substances 0.000 description 5
- 238000004811 liquid chromatography Methods 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 238000010829 isocratic elution Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- GGUOCFNAWIODMF-UHFFFAOYSA-N 4-chloroacetanilide Chemical compound CC(=O)NC1=CC=C(Cl)C=C1 GGUOCFNAWIODMF-UHFFFAOYSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 231100000024 genotoxic Toxicity 0.000 description 1
- 230000001738 genotoxic effect Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/36—Control of physical parameters of the fluid carrier in high pressure liquid systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8675—Evaluation, i.e. decoding of the signal into analytical information
- G01N30/8679—Target compound analysis, i.e. whereby a limited number of peaks is analysed
Landscapes
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Library & Information Science (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
Description
杂质 | 保留时间min | 分离度 | 对称因子 |
A | 13.828 | 8.56 | 0.92 |
B | 12.711 | 2.50 | 0.92 |
C | 18.048 | 8.79 | 0.93 |
D | 23.161 | 2.17 | 0.94 |
E | 26.258 | 3.94 | 0.93 |
F | 33.745 | 16.81 | 0.96 |
G | 28.928 | 4.51 | 0.90 |
H | 32.035 | 2.22 | 0.92 |
I | 51.148 | 5.51 | 0.94 |
J | 47.941 | 6.23 | 0.97 |
K | 1.358 | 30.88 | 1.19 |
L | 44.051 | 8.43 | 0.92 |
M | 24.491 | 2.83 | 0.98 |
N | 53.295 | n.a. | 0.94 |
对乙酰氨基酚 | 6.691 | 17.30 | 0.95 |
杂质 | 保留时间min | 分离度 | 对称因子 |
A | 13.727 | 8.39 | 0.93 |
B | 12.574 | 2.48 | 0.93 |
C | 17.977 | 8.68 | 0.92 |
D | 23.114 | 2.14 | 0.94 |
E | 26.241 | 4.00 | 0.93 |
F | 33.801 | 16.61 | 0.98 |
G | 28.941 | 4.45 | 0.92 |
H | 31.991 | 2.33 | 0.93 |
I | 51.187 | 5.53 | 0.94 |
J | 47.947 | 6.32 | 0.98 |
K | 1.317 | 26.89 | 1.24 |
L | 44.084 | 8.38 | 0.92 |
M | 24.444 | 2.84 | 0.97 |
N | 53.337 | n.a. | 0.94 |
对乙酰氨基酚 | 6.534 | 15.87 | 0.97 |
杂质 | 保留时间min | 分离度 | 对称因子 |
A | 13.849 | 8.56 | 0.98 |
B | 12.736 | 2.50 | 0.93 |
C | 18.103 | 8.73 | 1.17 |
D | 23.203 | 2.22 | 0.94 |
E | 26.323 | 4.03 | 0.93 |
F | 33.756 | 18.93 | 1.03 |
G | 29.009 | 4.53 | 0.92 |
H | 32.073 | 2.40 | 0.92 |
I | 51.193 | 5.10 | 0.98 |
J | 47.963 | 3.09 | 0.98 |
K | 1.349 | 16.63 | 1.32 |
L | 44.089 | 8.45 | 0.92 |
M | 24.553 | 2.86 | 0.97 |
N | 53.329 | n.a. | 0.94 |
对乙酰氨基酚 | 6.579 | 12.66 | 1.45 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010011431.3A CN111141850B (zh) | 2020-01-06 | 2020-01-06 | 对乙酰氨基酚原料药有关物质的液相检测分离方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010011431.3A CN111141850B (zh) | 2020-01-06 | 2020-01-06 | 对乙酰氨基酚原料药有关物质的液相检测分离方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111141850A true CN111141850A (zh) | 2020-05-12 |
CN111141850B CN111141850B (zh) | 2023-12-01 |
Family
ID=70523980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010011431.3A Active CN111141850B (zh) | 2020-01-06 | 2020-01-06 | 对乙酰氨基酚原料药有关物质的液相检测分离方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111141850B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114965754A (zh) * | 2022-05-13 | 2022-08-30 | 陕西必康制药集团控股有限公司 | 对乙酰氨基酚片中有关物质及抑菌剂的检测方法 |
CN115872885A (zh) * | 2022-11-25 | 2023-03-31 | 河北冀衡药业股份有限公司 | 一种控制对乙酰氨基酚杂质n含量的对乙酰氨基酚的制备方法 |
CN116106455A (zh) * | 2023-03-28 | 2023-05-12 | 上海赛默罗生物科技有限公司 | 取代的烟酰胺类药物中有关物质的检测方法 |
-
2020
- 2020-01-06 CN CN202010011431.3A patent/CN111141850B/zh active Active
Non-Patent Citations (1)
Title |
---|
MOHAMMED SHAHID ALI ET AL.: "Simultaneous Determination of Paracetamol, Chlorzoxazone, and Related Impurities 4-Aminophenol, 4-Chloroacetanilide, and p-Chlorophenol in Pharmaceutical Preparations by High-Performance Liquid Chromatography" * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114965754A (zh) * | 2022-05-13 | 2022-08-30 | 陕西必康制药集团控股有限公司 | 对乙酰氨基酚片中有关物质及抑菌剂的检测方法 |
CN114965754B (zh) * | 2022-05-13 | 2024-04-09 | 陕西必康制药集团控股有限公司 | 对乙酰氨基酚片中有关物质及抑菌剂的检测方法 |
CN115872885A (zh) * | 2022-11-25 | 2023-03-31 | 河北冀衡药业股份有限公司 | 一种控制对乙酰氨基酚杂质n含量的对乙酰氨基酚的制备方法 |
CN116106455A (zh) * | 2023-03-28 | 2023-05-12 | 上海赛默罗生物科技有限公司 | 取代的烟酰胺类药物中有关物质的检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN111141850B (zh) | 2023-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Scott et al. | Examination of five commercially available liquid chromatographic reversed phases (including the nature of the solute-solvent-stationary phase interactions associated with them) | |
CN111141850A (zh) | 对乙酰氨基酚原料药有关物质的液相检测分离方法 | |
Gomis et al. | Simultaneous determination of fat-soluble vitamins and provitamins in milk by microcolumn liquid chromatography | |
Cazes | Encyclopedia of Chromatography 2004 Update Supplement | |
CN104513286B (zh) | 一种分离纯化非达米星的方法 | |
CN104407077B (zh) | 一种mes,nhs残留的hplc检测方法 | |
CN105467021B (zh) | 一种hplc法分离测定帕立骨化醇原料药及制剂中有关物质的方法 | |
Hashem et al. | Chromatographic applications on monolithic columns: determination of triamcinolone, prednisolone and dexamethasone in pharmaceutical tablet formulations using a solid phase extraction and a monolithic column | |
CN107505409B (zh) | 一种测定人参皂苷rz1原料或制剂中异构体杂质人参皂苷rk1的方法 | |
CN111189937A (zh) | 阿司匹林原料药有关物质的液相检测分离方法 | |
CN106483202B (zh) | 一种分离和测定阿利维a酸与异构体的方法 | |
CN111307957A (zh) | 药物制剂中吐温80含量的检测方法 | |
CN111141851A (zh) | 含有阿司匹林的复方制剂有关物质的液相检测分离方法 | |
CN113759048B (zh) | 一种十八烷二酸单叔丁酯检验方法 | |
CN108445091B (zh) | 一种雌酚酮有关物质的hplc分析方法 | |
CN111141849A (zh) | 右美托咪定起始原料的位置异构体的液相检测分离方法 | |
CN110412164B (zh) | 一种盐酸美西律的有关物质的检测方法 | |
Layton et al. | UPLC Separation for the analysis of cannabinoid content in cannabis flowers and extracts | |
CN111157630B (zh) | 一种油酸苄酯及黄体酮注射液中油酸苄酯的检测方法 | |
CN112305110A (zh) | 适用于乙酯型和甘油酯类型鱼油产品塑化剂的检测方法 | |
CN111721855A (zh) | 一种含对乙酰氨基酚、氢溴酸右美沙芬和琥珀酸多西拉敏的药物制剂有关物质的测定方法 | |
CN112595788B (zh) | 一种分离(R)、(S)-1-(α-萘基)缩水甘油基醚的高效液相色谱方法 | |
CN117269375B (zh) | 一种测定维生素a醋酸酯粉中有关物质的方法 | |
CN113030281B (zh) | 一种分离化合物d和/或j的方法 | |
CN111380966A (zh) | 一种测定维生素k1原料药有关物质的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230111 Address after: Floor 9, building F6, Jiangsu life science and Technology Innovation Park, No. 9, Weidi Road, Qixia District, Nanjing, Jiangsu 210033 Applicant after: SKYRUN PHARMA Co.,Ltd. Applicant after: BAIYUNSHAN HEJIGONG PHARMACEUTICAL FACTORY, GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS Co.,Ltd. Address before: Floor 9, building F6, Jiangsu life science and Technology Innovation Park, No. 9, Weidi Road, Qixia District, Nanjing, Jiangsu 210033 Applicant before: SKYRUN PHARMA Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |